Skip to main content
  • Register
  • Help
  • Contact us

Europe midday: Stocks buoyed by US bank earnings

Thu 15 April 2021 12:23 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Market latest

FTSE 100 | FTSE 250 | Paris CAC 40 | Dow Jones | NASDAQ

7076.17 | Positive 36.87 (0.52%)
Graph

Prices delayed by at least 15 minutes

(Sharecast News) - Stocks in Europe were holding slightly higher come midday, buoyed by a strong quarterly update from one of the largest US lenders.

"European stocks are charging higher after the US earning season kicked off on the right foot. US banks are often considered a proxy for the broader economy. As a result, their earnings are strong drivers of sentiment," market analyst for the UK and EAMA at Oanda.

"The upbeat numbers served to reinforce expectations of a strong US economic recovery. If the world's largest economy is performing well, this is good news for the global economy and risk sentiment."

As of 1228 GMT, the benchmark Stoxx 600 had added 0.33% to 437.99, the Dax had risen 0.27% to 15,250.86 and the Cac-40 had advanced 0.24% to 6,223.49.

In the background meanwhile, Bank of America's just released and stronger-than-expected first quarter earnings report and upbeat outlook was feeding the risk-on mood.

Back on the Continent, Carlsberg was a top gainer after analysts at JP Morgan hiked their target price for the company's shares to DKK 1,230.0, citing its "outperformance" in 'beyond beer' segments China strength and stability in Russia.

But it was shares of Anheuser Busch Inbev that were topping gainers on the Stoxx 600, with positive read-across from Carlsberg helping to lift the stock price towards technical resistance at their end-2020 highs.

On the mergers and acquisitions front, DNB, Norway's largest lender, said it had inked an agreement to take over its smaller rival, Sbanken, for NOK11.1bn.

GlaxoSmithKline shares were also on the move, reversing early losses triggered by news that it had halted a trial for its cancer treatment Feladilimab.

According to the Financial Times, hedge fund Elliott had built up a multi-billion pound stake in the drugmaker.

Shares of Deliveroo were down 3% after the company posted lacklustre guidance for the first quarter.

There was little fresh news on the economic front for investors to chew on, with final estimates for harmonised consumer prices in France and Germany for the month of March both printing in line with initial estimates.

Further afield nonetheless, investors were monitoring the news around the ongoing tensions on the Ukraining-Russian border.

    Daily market update emails

    • FTSE 100 riser and faller updates
    • Breaking market news, plus the latest share research, tips and broker comments

    Register now for free market updates

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.